Global Non Small-Cell Lung Cancer Market is Segmented By Drug Class(Epidermal Growth Factor Receptor (EGFR) Inhibitors, Anaplastic Lymphoma Kinase (ALK) Inhibitors, ROS1 Inhibitors, BRAF Inhibitors, Others), By Type(Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Others), By Treatment(Chemotherapy, Targeted Therapy, Immunotherapy), By End-user(Hospitals, Homecare, Specialty Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
$4350
$4350
$4350
$4350
$4350
$4350